Gambogic acid-galactose-HPMA (N-(2-hydroxypropyl)methacrylamide) high-molecular copolymer, and preparation method and application thereof

A high molecular copolymer, galactose technology, applied in the field of gambogic acid-galactose-HPMA high molecular copolymer and its preparation, can solve the problems of hematopoietic system and immune function, limited clinical research, large toxic and side effects, etc. Achieve good biocompatibility, prolong residence time, and enhance targeting

Inactive Publication Date: 2017-06-13
LIAONING UNIVERSITY
View PDF4 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the past 20 years, scholars at home and abroad have carried out a lot of in-depth and systematic research on Garcinia Cambogia. Garcinia Cambogia and its active ingredient, Gambogic Acid, have a wide range of pharmacological activities, mainly including anti-tumor, anti-bacterial, anti-inflammatory, anti-viral, and anti...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Gambogic acid-galactose-HPMA (N-(2-hydroxypropyl)methacrylamide) high-molecular copolymer, and preparation method and application thereof
  • Gambogic acid-galactose-HPMA (N-(2-hydroxypropyl)methacrylamide) high-molecular copolymer, and preparation method and application thereof
  • Gambogic acid-galactose-HPMA (N-(2-hydroxypropyl)methacrylamide) high-molecular copolymer, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Embodiment 1 A kind of gambogic acid-galactose-HPMA polymer copolymer

[0031] Its structure is as follows:

[0032]

[0033] The preparation method of the compound is as follows: first, the galactose derivative C is prepared by using D-galactose as a raw material; The galactose derivative C, the gambogic acid derivative D and HPMA are condensed into a gambogic acid-galactose-HPMA polymer copolymer.

[0034]

[0035] in,

[0036] 1. The synthesis of galactose derivative C specifically comprises the following steps:

[0037]

[0038] 1.1) Dissolve 2.0g (11.2mmol) of D-galactose in 100mL of acetone, add 1.0-2.5mL of concentrated sulfuric acid, stir overnight at room temperature, the solution turns bright yellow, add 20% potassium carbonate solution 20mL, a large amount of Suction filtration, distill off the acetone in the filtrate, extract the remaining filtrate with 5×40ml of chloroform, wash the chloroform with 2×15mL of distilled water, add anhydrous sodium...

Embodiment 2

[0047] The pharmacodynamics test of embodiment 2 gambogic acid-galactose-HPMA macromolecule copolymer

[0048] The copolymer provided in Example 3 was used as the test sample, which showed excellent anti-tumor effects as shown in the following pharmacodynamic tests.

[0049] Growth inhibitory activity against various cancer cells (GI 50 ) Assay method: After the tumor cells were digested with trypsin, they were dispersed into single cells and suspended in RPMI1640 medium containing penicillin (25 U / ml) and streptomycin (25 μg / ml). Cells were seeded in 96-well culture plates (Corning Incorporated) at 37°C with 5% CO 2 After culturing for 24 hours under the condition of 100% relative humidity, the culture solution was discarded, and the culture solution containing a series of concentrations of test samples (equivalent to an equivalent amount of gambogic acid) was added. Parallel wells were set for each concentration, and cultured After 24 hours, discard the culture solution co...

Embodiment 3

[0057] The safety test (acute toxicity) of embodiment 3 gambogic acid-galactose-HPMA polymer copolymer

[0058] Gambogic acid-galactose-HPMA macromolecular copolymers were administered by intragastric administration to mice, and the results showed that the copolymers had certain toxicity to the circulatory system, and the animals in the high-dose group showed little movement in 10 to 24 hours after administration. Rats excrete thin feces, and there is light yellow thin feces pollution around the anus. Death occurred within 24 to 48 hours after administration. The dead mice were dissected, the liver turned white, and the rest of the organs were normal. The surviving mice in each group were continuously observed for 14 days, and no abnormalities were found in food intake, drinking water, general status and activities. After the observation period, the mice were sacrificed, and no abnormalities were found in the liver and major organs by naked eye observation.

[0059] The copol...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a gambogic acid-galactose-HPMA (N-(2-hydroxypropyl)methacrylamide) high-molecular copolymer. The structural formula is shown as (I) in the specification. In the formula, x=5-10 mol%, y=5-10 mol%, z=80-90 mol%, Mn=2.2*10<4>, and Mw/Mn=1.45. A preparation method comprises the following steps: preparing a galactose derivative C by taking D-galactose as a preparation raw material; reacting gambogic acid oxalamide and methylacryloyl to prepare a gambogic acid derivative D; and finally, performing condensation on the galactose derivative C, the gambogic acid derivative D and HPMA to obtain the gambogic acid-galactose-HPMA high-molecular copolymer. After being used in a drug for treating a neoplastic disease, the copolymer has a targeted intelligent drug release functional and achieves a favorable inhibition effect for liver cancer, lung cancer and colon cancer.

Description

technical field [0001] The invention belongs to the field of macromolecule anti-tumor targeted drugs, and in particular relates to a gambogic acid-galactose-HPMA polymer copolymer and its preparation method and application. Background technique [0002] Gambogic Acid (Gambogic Acid, GA, C38H4408) is one of the active ingredients in the traditional Chinese medicine Gambogic. In the past 20 years, scholars at home and abroad have carried out a lot of in-depth and systematic research on Garcinia Cambogia. Garcinia Cambogia and its active ingredient, Gambogic Acid, have a wide range of pharmacological activities, mainly including anti-tumor, anti-bacterial, anti-inflammatory, anti-viral, and anti-inflammatory. It has strong anti-tumor activity on various tumors and has become a hotspot in the anti-tumor research of natural products in recent years. It has large toxic and side effects and low selectivity. Function will also have an impact, which limits the current clinical resea...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K47/58A61K31/352C08F220/58C08F220/28C08F222/38A61P35/00
CPCA61K31/352C08F220/58C08F220/282C08F222/385
Inventor 陈烨刘举王洋丁实李胜男周子筠
Owner LIAONING UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap